Sentinel lymph node biopsy in women with pT1a or "microinvasive" breast cancer

Breast

Volumn 17, Issue 4, 2008, Pages 395-400

  Fortunato, Lucio ^a   Santoni, Marcello ^b   Drago, Stefano ^c   Gucciardo, Giacomo ^d   Farina, Massimo ^a   Cesarini, Claudio ^e   Cabassi, Alessandro ^f   Tirelli, Claudio ^g   Terribile, Daniela ^h   Grassi, Gian Battista ^c   De Fazio, Smeralda ⁱ   Vitelli, Carlo Eugenio ^a  

^a SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^b San Giuseppe Hospital   (Italy)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^e SANDRO PERTINI HOSPITAL   (Italy)

^f S EUGENIO HOSPITAL   (Italy)

^g NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^h FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

ⁱ FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Chemotherapy; Microinvasion; Minimal breast cancer; Sentinel lymph node; Stage

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; SEX HORMONE; TAMOXIFEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; MINIMALLY INVASIVE SURGERY; PATIENT PARTICIPATION; PREDICTION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TREATMENT INDICATION;

EID: 48649095865     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2008.03.003     Document Type: Article

References (47)

1. Silverstein M.J., Gierson E.D., Waisman J.R., Senofsky G.M., Colburn W.J., and Gamagami P. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?. Cancer 73 (1994) 664-667
2. Harris J.R., Lippman M.E., Veronesi U., and Willet W. Breast cancer. N Engl J Med 327 (1992) 473-480
3. Fisher B., Bauer M., Wickerham D.L., Redmond C.K., Fisher E.R., Cruz A.B., et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update. Cancer 52 (1983) 1551-1557
4. Fortunato L., Drago S., Vitelli C.E., Santoni M., Gucciardo G., Cabassi A., et al. Sentinel lymph node biopsy in breast cancer. Experience of the Rome Breast Cancer Study Group. Chir Ital 58 (2006) 689-696
5. Sobin L.H., and Wittekind C. TNM classification of malignant tumors (2002), UICC, Wiley-Liss, New York
6. Berry D.A., Cronin K.A., Plevritis S.K., Fryback D.G., Clarke L., Zelen M., et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353 (2005) 1784-1792
7. Gotzesche P.C., and Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 18 (2006) CD001877
8. Tabar L., Smith R.A., Vitak B., Yen M.F., Chen T.H., Warwick J., et al. Mammographic screening: a key factor in the control of breast cancer. Cancer J 9 (2003) 15-27
9. Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
10. Barone J.E., Tucker J.B., Perez J.M., Odom S.R., and Ghevariya V. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer. Am Surg 71 (2005) 66-70
11. Giuliano A.E., Barth A.M., Spivack B., Beitsch P.D., and Evans S.W. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. J Am Coll Surg 183 (1996) 185-189
12. Barth A., Craig P.H., and Silverstein M.J. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 79 (1997) 1918-1922
13. Port E.R., Tan L.K., Borgen P.I., and Van Zee K.J. Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma. Ann Surg Oncol 5 (1998) 23-27
14. White R.E., Vezeridis M.P., Konstadoulakis M., Cole B.F., Wanebo H.J., and Bland K.I. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg 183 (1996) 575-582
15. Brenin D.R., Manasseh D.M., El-Tamer M., Troxel A., Schnabel F., Ditkoff B.A., et al. Factors correlating with lymph node metastases in patients with T1 breast cancer. Ann Surg Oncol 8 (2001) 432-437
16. Rivadeneira D.E., Simmons R.M., Christos P.J., Hanna K., Daly J.M., and Osborne M.P. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg 191 (2000) 1-6 discussion 6-8
17. Markopoulos C., Kouskos E., Gogas H., Mandas D., Kakisis J., and Gogas J. Factors affecting axillary lymph node metastases in patients with T1 breast carcinoma. Am Surg 66 11 (2000) 1011-1013
18. Visser T.J., Haan M., Keidan R., Lucas R., Ingold J., Glover J., et al. T1a and T1b breast cancer: a twelve-year experience. Am Surg 63 (1997) 621-626
19. Mincey B.A., Bammer T., Atkinson E.J., and Perez E.A. Role of axillary node dissection in patients with T1a and T1b breast cancer: Mayo Clinic experience. Arch Surg 136 (2001) 779-782
20. Mann G.B., Port E.R., Rizza C., Tan L.K., Borgen P.I., and Van Zee K.J. Six-year follow-up of patients with microinvasive, T1a and T1b breast carcinoma. Ann Surg Oncol 6 (1999) 591-598
21. Whitten T.M., Fraser H.R., Christensen W.N., and Turk P.S. Axillary node metastasis in stage T1a breast cancer: a pathologic review of 82 patients. Am Surg 63 (1997) 144-149
22. McGee J.M., Youmans R., Clingan F., Mainar K., Bellefeuille C., and Berry B. The value of axillary dissection in T1a breast cancer. Am J Surg 172 (1996) 501-505
23. Schneidereit N.P., Davis N., Mackinnon M., Speers C.H., Truong P.T., and Olivotto I. T1a breast carcinoma and the role of axillary dissection. Arch Surg 138 (2003) 832-837
24. Broekhuizen L.N., Wijsman J.H., Peterse J.L., and Rutgers E.J. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. Eur J Surg Oncol 32 (2006) 502-506
25. Cserni G., Bianchi S., Vezzosi V., Arisio R., Bori R., Peterse J.L., et al. Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study. Pathol Oncol Res 13 (2007) 5-14
26. Gajdos C., Tartter P.I., and Bleiweiss I.J. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg 230 (1999) 692-696
27. Adamovich T.L., and Simmons R.M. Ductal carcinoma in situ with microinvasion. Am J Surg 186 (2003) 112-116
28. Klauber-DeMore N., Tan L.K., Liberman L., Kaptain S., Fey J., Borgen P., et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?. Ann Surg Oncol 7 (2000) 636-642
29. Jimenez R.E., and Visscher D.W. Clinicopathologic analysis of microscopically invasive breast carcinoma. Hum Pathol 29 (1998) 1412-1419
30. Zavotsky J., Hansen N., Brennan M.B., Turner R.R., and Giuliano A.E. Lymph node metastasis from ductal carcinoma in situ with microinvasion. Cancer 85 (1999) 2439-2443
31. Intra M., Zurrida S., Maffini F., Sonzogni A., Trifirò G., Gennari R., et al. Sentinel lymph node metastases in microinvasive breast cancer. Ann Surg Oncol 10 (2003) 1160-1165
32. Zavagno G., Belardinelli V., Marconato R., Carcoforo P., Franchini Z., Scalco G., et al. Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion. Breast 16 (2007) 146-151
33. Zavagno G., Carcoforo P., Marconato R., Franchini Z., Scalco G., Burelli P., et al. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. BMC Cancer 5 (2005) 28
34. Intra M., Rotmensz N., Veronesi P., Colleoni M., Iodice S., Paganelli G., et al. Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European Institute of Oncology on 854 patients in 10 years. Ann Surg 247 (2008) 315-319
35. Tabar L., Tony Chen H.H., Amy Yen M.F., Tot T., Tung T.H., Chen L.S., et al. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14 mm invasive breast carcinoma. Cancer 101 (2004) 1745-1759
36. Thurfjell E., Thurjell M.G., and Lindgren A. Mammographic finding as predictor of survival in 1-9 mm invasive breast cancers. Worst prognosis for cases presenting as calcifications alone. Breast Cancer Res Treat 67 (2001) 177-180
37. Mendez E., Fey J.V., Cody H., Borgen P.I., and Sclafani L.M. Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology?. Ann Surg Oncol 12 (2005) 24-28
38. Schrenk P., Rieger R., Shamiyeh A., and Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88 (2000) 608-614
39. Schulze T., Mucke J., Markwardt J., Schlag P.M., and Bembenek A. Long term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol 93 (2006) 109-119
40. Langer I., Guller U., Koechli O.R., Berelaz G., Singer G., Schaer G., et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245 (2007) 452-461
41. Schijven M.P., Vingerhoets A.J., Rutten H.J., Nieuwenhuijzen G.A., Rouen R.M., Bussel M.E., et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29 (2003) 341-350
42. Hanrahan W.O., Valero V., Gonzalez-Angulo A.M., and Hortobagyi G.N. Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature. J Clin Oncol 24 (2006) 2113-2122
43. NCCN practice guidelines in oncology, v.2.2007. Available online www.nccn.org/professional/physician_gls/PDF/breast.pdf.
44. Houvenaeghel G., Nos C., Mignotte H., Classe J.M., Giard S., Rouanet P., et al. Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement - Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J Clin Oncol 24 (2006) 1814-1822
45. Van Zee K.J., Manasseh D.M.E., Bevilacqua J.L., Boolbol S.K., Fey JV., Tan L.K., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10 (2003) 1140-1151
46. Hwang R.F., Krisnamurthy S., Hunt K.K., Mirza N., Ames F.C., Feig B., et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10 (2003) 248-254
47. Barranger E., Coutant C., Flahault A., Delpech Y., Darai E., Uzan S., et al. An axillary scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 91 (2005) 113-119